Coherus Oncology (CHRS) Proxy filing summary

Voting matters and shareholder proposals

• Shareholders are asked to vote on several proposals at the Annual Shareholder Meeting scheduled for May 27, 2026, at 1:30 pm PST.

• One key proposal is to reprice employee stock options with strike prices of $5 and above to the closing price on the date of the meeting.

• The stock option repricing proposal requires a majority of votes cast "FOR" to pass.

Executive compensation and say-on-pay

• The proxy includes a proposal to reprice employee stock options, directly impacting executive and employee compensation.

Shareholder rights and capital structure

• Shareholders are encouraged to participate in voting, with options to vote electronically or by phone through the proxy solicitor.